Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series

Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series

Aims 68 Ga-Prostate-specific membrane antigen (PSMA) PET/CT is widely used in patients with biochemical recurrence (BCR) after radical prostatectomy. We collected data about patients staged with PSMA PET/CT after BCR (PSA  7 ( p  = 0.004) and TTR 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical & translational oncology 2021-02, Vol.23 (2), p.364-371
Hauptverfasser: Francolini, G., Detti, B., Bottero, M., Zilli, T., Lancia, A., Bruni, A., Borghesi, S., Mariotti, M., Castellucci, P., Fanti, S., Filippi, A. R., Teriaca, M. A., Maragna, V., Aristei, C., Mazzeo, E., Livi, L., Ingrosso, G.
Format: Artikel
Sprache:eng
Schlagworte:
Medicine
Medicine & Public Health
Oncology
Research Article
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims 68 Ga-Prostate-specific membrane antigen (PSMA) PET/CT is widely used in patients with biochemical recurrence (BCR) after radical prostatectomy. We collected data about patients staged with PSMA PET/CT after BCR (PSA  7 ( p  = 0.004) and TTR 
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-020-02427-2